• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于免疫反应性胰蛋白酶原水平随年龄下降,囊性纤维化的新生儿筛查变得复杂。

Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.

作者信息

Rock M J, Mischler E H, Farrell P M, Wei L J, Bruns W T, Hassemer D J, Laessig R H

机构信息

Department of Pediatrics, University of Wisconsin-Madison 53792.

出版信息

Pediatrics. 1990 Jun;85(6):1001-7.

PMID:2187173
Abstract

Detection of elevated levels of immunoreactive trypsinogen (IRT) in dried neonatal blood spots has been used as a screening test for cystic fibrosis. In other cystic fibrosis newborn-screening studies, a sweat chloride test is generally performed only if an infant has a persistent IRT level above a selected cutoff value on both the initial and subsequent specimens. Neither the timing of the second specimen nor the value of the cutoff point for the second specimen has been comprehensively evaluated. In this randomized, controlled study, 145,024 infants were screened in the neonatal period for cystic fibrosis using the 99.8 percentile (180 ng/mL) as the neonatal cutoff point. A total of 129 infants had elevated neonatal IRT levels and had negative results on sweat tests (false-positive by IRT screening). A total of 54 children with cystic fibrosis were identified in the screened and comparison groups. Excluding patients with meconium ileus, 4 infants with cystic fibrosis had neonatal IRT values less than 180 ng/mL, and an additional 9 infants with cystic fibrosis had values decline to less than 180 ng/mL within the first 2 1/2 months of age. The IRT values of infants with and without cystic fibrosis overlapped considerably beyond 30 days of age. These findings suggest that further refinement of cystic fibrosis screening methodology will be necessary to achieve an acceptable sensitivity and specificity.

摘要

检测干血斑中免疫反应性胰蛋白酶原(IRT)水平升高已被用作囊性纤维化的筛查试验。在其他囊性纤维化新生儿筛查研究中,通常仅当婴儿的初始样本和后续样本的IRT水平持续高于选定的临界值时才进行汗液氯化物试验。第二个样本的采集时间和第二个样本的临界值均未得到全面评估。在这项随机对照研究中,145,024名婴儿在新生儿期接受了囊性纤维化筛查,使用第99.8百分位数(180 ng/mL)作为新生儿临界值。共有129名婴儿的新生儿IRT水平升高,但汗液试验结果为阴性(IRT筛查假阳性)。在筛查组和对照组中总共识别出54名囊性纤维化患儿。排除胎粪性肠梗阻患者后,4名囊性纤维化婴儿的新生儿IRT值低于180 ng/mL,另外9名囊性纤维化婴儿在出生后头2个半月内IRT值降至低于180 ng/mL。30日龄以上患囊性纤维化和未患囊性纤维化婴儿的IRT值有相当大的重叠。这些发现表明,要实现可接受的敏感性和特异性,有必要进一步完善囊性纤维化筛查方法。

相似文献

1
Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.由于免疫反应性胰蛋白酶原水平随年龄下降,囊性纤维化的新生儿筛查变得复杂。
Pediatrics. 1990 Jun;85(6):1001-7.
2
Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.科罗拉多州基于两层免疫反应性胰蛋白酶原的囊性纤维化新生儿筛查:筛查效果与诊断结果
J Pediatr. 2005 Sep;147(3 Suppl):S83-8. doi: 10.1016/j.jpeds.2005.08.005.
3
Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.通过检测胰蛋白酶原浓度进行全州范围内囊性纤维化新生儿筛查的效果。
N Engl J Med. 1991 Sep 12;325(11):769-74. doi: 10.1056/NEJM199109123251104.
4
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.威斯康星州囊性纤维化新生儿筛查:九年常规胰蛋白酶原/DNA检测经验
J Pediatr. 2005 Sep;147(3 Suppl):S73-7. doi: 10.1016/j.jpeds.2005.08.004.
5
Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.通过新生儿筛查确定的囊性纤维化婴儿纵向免疫反应性胰蛋白酶原下降的遗传和生理相关性。
J Pediatr. 2006 Nov;149(5):650-657. doi: 10.1016/j.jpeds.2006.07.026.
6
Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.囊性纤维化新生儿筛查的营养益处。威斯康星州囊性纤维化新生儿筛查研究组。
N Engl J Med. 1997 Oct 2;337(14):963-9. doi: 10.1056/NEJM199710023371403.
7
A survey of newborn screening for cystic fibrosis in Europe.欧洲囊性纤维化新生儿筛查调查。
J Cyst Fibros. 2007 Jan;6(1):57-65. doi: 10.1016/j.jcf.2006.05.008. Epub 2006 Jul 25.
8
A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.一种新的囊性纤维化新生儿筛查算法:免疫反应性胰蛋白酶(IRT)/ IRT1升高/基因检测。
J Pediatr. 2009 Nov;155(5):618-22. doi: 10.1016/j.jpeds.2009.03.057. Epub 2009 Jun 21.
9
Neonatal screening for cystic fibrosis in Wisconsin.
Wis Med J. 1989 Mar;88(3):14-8.
10
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.通过对免疫反应性胰蛋白酶原的初步分析,阐明影响囊性纤维化新生儿筛查的实验室和临床变量。
Pediatrics. 2009 Feb;123(2):e338-46. doi: 10.1542/peds.2008-1681.

引用本文的文献

1
Neonatal Screening for Cystic Fibrosis in Hungary-First-Year Experiences.匈牙利新生儿囊性纤维化筛查——第一年经验
Int J Neonatal Screen. 2023 Aug 23;9(3):47. doi: 10.3390/ijns9030047.
2
Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening.囊性纤维化新生儿筛查中的诊断与沟通挑战
Life (Basel). 2023 Jul 28;13(8):1646. doi: 10.3390/life13081646.
3
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors.因免疫反应性胰蛋白酶原水平低于项目临界值导致的囊性纤维化新生儿筛查漏诊病例:一项全国性危险因素调查
Int J Neonatal Screen. 2022 Oct 27;8(4):58. doi: 10.3390/ijns8040058.
4
Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present.托斯卡纳的囊性纤维化:随着时间的推移,新生儿筛查策略的演变至今。
Ital J Pediatr. 2021 Jan 6;47(1):2. doi: 10.1186/s13052-020-00948-8.
5
Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.单纯新生儿筛查不足以改善囊性纤维化的肺部结局。
J Cyst Fibros. 2021 May;20(3):492-498. doi: 10.1016/j.jcf.2020.06.002. Epub 2020 Jun 13.
6
The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.CFTR 基因发现对囊性纤维化的诊断、咨询和预防治疗的影响。
Genes (Basel). 2020 Apr 8;11(4):401. doi: 10.3390/genes11040401.
7
Screening for cystic fibrosis in New York State: considerations for algorithm improvements.纽约州囊性纤维化的筛查:算法改进的考量因素
Eur J Pediatr. 2016 Feb;175(2):181-93. doi: 10.1007/s00431-015-2616-3. Epub 2015 Aug 21.
8
Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.使用下一代测序技术改进囊性纤维化新生儿筛查:一项技术可行性研究。
Genet Med. 2016 Mar;18(3):231-8. doi: 10.1038/gim.2014.209. Epub 2015 Feb 12.
9
A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.基于决策树的方法对囊性纤维化新生儿筛查策略的成本比较。
Pediatrics. 2012 Feb;129(2):e339-47. doi: 10.1542/peds.2011-0096. Epub 2012 Jan 30.
10
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.比较两种常见的新生儿筛查后诊断和治疗起始策略的囊性纤维化的诊断和治疗起始年龄。
J Cyst Fibros. 2012 Mar;11(2):150-3. doi: 10.1016/j.jcf.2011.10.002. Epub 2011 Nov 21.